Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1960 1
1962 4
1968 1
1970 3
1974 1
1977 4
1978 2
1980 2
1981 1
1982 1
1983 3
1984 7
1985 5
1986 4
1987 5
1988 2
1989 2
1990 3
1991 8
1992 5
1993 5
1994 6
1995 8
1996 7
1997 4
1998 7
1999 5
2000 7
2001 3
2002 7
2003 3
2004 4
2005 9
2006 5
2007 7
2008 10
2009 11
2010 10
2011 13
2012 7
2013 11
2014 13
2015 14
2016 13
2017 23
2018 27
2019 39
2020 31
2021 41
2022 35
2023 61
2024 62
2025 63
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

581 results

Results by year

Filters applied: . Clear all
Page 1
Dopamine receptors: from structure to function.
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Missale C, et al. Among authors: nash sr. Physiol Rev. 1998 Jan;78(1):189-225. doi: 10.1152/physrev.1998.78.1.189. Physiol Rev. 1998. PMID: 9457173 Free article. Review.
Hypospadias.
Mole RJ, Nash S, MacKenzie DN. Mole RJ, et al. Among authors: nash s. BMJ. 2020 Jun 17;369:m2070. doi: 10.1136/bmj.m2070. BMJ. 2020. PMID: 32554436 No abstract available.
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell.
Hara Y, Jha MK, Huang JY, Han Y, Langohr IM, Gaglia G, Zhu C, Piepenhagen P, Gayvert K, Lim WK, Asrat S, Nash S, Jacob-Nara JA, Orengo JM, Bangari DS, de Rinaldis E, Mattoo H, Hicks A. Hara Y, et al. Among authors: nash s. Allergy. 2025 Feb;80(2):440-461. doi: 10.1111/all.16338. Epub 2024 Oct 17. Allergy. 2025. PMID: 39418114 Free PMC article.
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S. Seddon B, et al. Among authors: nash s. Lancet Oncol. 2017 Oct;18(10):1397-1410. doi: 10.1016/S1470-2045(17)30622-8. Epub 2017 Sep 4. Lancet Oncol. 2017. PMID: 28882536 Free PMC article. Clinical Trial.
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial.
De Corso E, Canonica GW, Heffler E, Springer M, Grzegorzek T, Viana M, Horváth Z, Mullol J, Gevaert P, Michel J, Peters AT, Wagenmann M, Zaghloul S, Zhang M, Corbett M, Nash S, Angello JT, Radwan A, Deniz Y, Martin A, Hellings PW. De Corso E, et al. Among authors: nash s. Lancet Respir Med. 2025 Dec;13(12):1067-1077. doi: 10.1016/S2213-2600(25)00287-5. Epub 2025 Sep 28. Lancet Respir Med. 2025. PMID: 41033334 Clinical Trial.
Protecting lemurs--response.
Schwitzer C, Chikhi L, Donati G, Irwin M, Johnson SE, Mittermeier RA, Peacock H, Ratsimbazafy J, Razafindramanana J, Louis EE Jr, Colquhoun IC, Tinsman J, Dolch R, Lafleur M, Nash S, Patel E, Randrianambinina B, Rasolofoharivelo T, Wright PC. Schwitzer C, et al. Among authors: nash s. Science. 2014 Apr 25;344(6182):358-60. doi: 10.1126/science.344.6182.358-c. Science. 2014. PMID: 24763571 No abstract available.
Characterizing trachoma elimination using serology.
Kamau E, Ante-Testard PA, Gwyn S, Blumberg S, Abdalla Z, Aiemjoy K, Amza A, Aragie S, Arzika AM, Awoussi MS, Bailey RL, Butcher R, Callahan EK, Chaima D, Dawed AA, Díaz MIS, Domingo AS, Drakeley C, Elshafie BE, Emerson PM, Fornace K, Gass K, Goodhew EB, Hammou J, Harding-Esch EM, Hooper PJ, Kadri B, Kalua K, Kanyi S, Kasubi M, Kello AB, Ko R, Lammie PJ, Lescano AG, Maliki R, Masika MP, Migchelsen SJ, Nassirou B, Nesemann JM, Parameswaran N, Pomat W, Renneker KK, Roberts C, Rymil P, Sata E, Senyonjo L, Seife F, Sillah A, Sokana O, Srivathsan A, Tadesse Z, Taleo F, Taylor EM, Tekeraoi R, Togbey K, West SK, Wickens K, William T, Wittberg DM, Yeboah-Manu D, Youbi M, Zeru T, Keenan JD, Lietman TM, Solomon AW, Nash SD, Martin DL, Arnold BF. Kamau E, et al. Among authors: nash sd. Nat Commun. 2025 Jul 1;16(1):5545. doi: 10.1038/s41467-025-60581-z. Nat Commun. 2025. PMID: 40593530 Free PMC article.
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response.
Bland P, Saville H, Wai PT, Curnow L, Muirhead G, Nieminuszczy J, Ravindran N, John MB, Hedayat S, Barker HE, Wright J, Yu L, Mavrommati I, Read A, Peck B, Allen M, Gazinska P, Pemberton HN, Gulati A, Nash S, Noor F, Guppy N, Roxanis I, Pratt G, Oldreive C, Stankovic T, Barlow S, Kalirai H, Coupland SE, Broderick R, Alsafadi S, Houy A, Stern MH, Pettit S, Choudhary JS, Haider S, Niedzwiedz W, Lord CJ, Natrajan R. Bland P, et al. Among authors: nash s. Nat Genet. 2023 Aug;55(8):1311-1323. doi: 10.1038/s41588-023-01460-5. Epub 2023 Jul 31. Nat Genet. 2023. PMID: 37524790 Free PMC article.
581 results